Aim: To evaluate the variation of peripheral alterations in different retinal diseases over a period of >3 years by using wide-field fundus autofluorescence (FAF) scanning laser ophthalmoscopy (SLO). Methods: A total of 26 eyes from 13 patients (median age 66 years, range 19-80) with age-related macular degeneration and other retinal degenerations were examined. In 2009, the Optos P200CAF prototype and from 2012 onwards, the Optos 200Tx (Optos plc, Scotland) were used for wide-field FAF SLO (excitation 532 nm). Results: The area involvement in outer retinal pathological alterations, such as atrophy and mottling of the retinal pigment epithelium far beyond the vascular arcades, was readily and better visualized within one image frame using wide-field FAF as compared to pseudocolor SLO of the same device. Over time, progression of existing and the development of de novo peripheral lesions were recorded with a concomitant enlargement of central lesions. In two cases (unilateral paravenous pigmented choroidal atrophy and suspected phenocopy of retinal dystrophy), no longitudinal changes of the topographic distribution of peripheral FAF intensities were noted. Conclusions: Wide-field FAF SLO allows the mapping of dynamic changes at the outer retina far beyond the vascular arcades. While its ability to detect and monitor these changes appears to be better than that of pseudocolor imaging, wide-field FAF SLO may not only be helpful to assess more widespread retinal dysfunction, but may also be useful for longitudinal assessments in natural history studies and interventional clinical trials.

1.
Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ: In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718-729.
2.
von Ruckmann A, Fitzke FW, Bird AC: Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol 1995;79:407-412.
3.
Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF: Fundus autofluorescence imaging: review and perspectives. Retina 2008;28:385-409.
4.
Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K: Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:4470-4476.
5.
Fleckenstein M, Charbel Issa P, Fuchs HA, Finger RP, Helb HM, Scholl HP, Holz FG: Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry. Eye (Lond) 2009;23:567-575.
6.
Neubauer AS, Kernt M, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW: Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol 2008;246:229-235.
7.
Neubauer AS, Yu A, Haritoglou C, Ulbig MW: Peripheral retinal changes in acute retinal necrosis imaged by ultra widefield scanning laser ophthalmoscopy. Acta Ophthalmol Scand 2005;83:758-760.
8.
Heussen FM, Tan CS, Sadda SR: Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center. Invest Ophthalmol Vis Sci 2012;53:6526-6531.
9.
Tan CS, Heussen F, Sadda SR: Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Ophthalmology 2013;120:1271-1277.
10.
Oishi M, Oishi A, Ogino K, Makiyama Y, Gotoh N, Kurimoto M, Yoshimura N: Wide-field fundus autofluorescence abnormalities and visual function in patients with cone and cone-rod dystrophies. Invest Ophthalmol Vis Sci 2014;55:3572-3577.
11.
Witmer MT, Kozbial A, Daniel S, Kiss S: Peripheral autofluorescence findings in age-related macular degeneration. Acta Ophthalmol 2012;90:e428-e433.
12.
Reznicek L, Seidensticker F, Stumpf C, Langer J, Thurau S, Ulbig MW, Kampik A, Neubauer A, Kernt M: Wide-field fundus autofluorescence in non-infectious posterior uveitis. Ophthalmologe 2014;111:543-547.
13.
Slotnick S, Sherman J: Panoramic autofluorescence: highlighting retinal pathology. Optom Vis Sci 2012;89:E575-E584.
14.
Reznicek L, Wasfy T, Stumpf C, Kampik A, Ulbig M, Neubauer AS, Kernt M: Peripheral fundus autofluorescence is increased in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012;53:2193-2198.
15.
Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG: Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol 2009;54:96-117.
16.
Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF: Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2015;122:809-816.
17.
Singer M, Tan CS, Bell D, Sadda SR: Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina 2014;34:1736-1742.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.